Overview

PureTech is a clinical stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders and inflammatory and immunological diseases, among others.

For Investor Relations inquiries, please contact PureTech's Investor Relations team at: ir@puretechhealth.com.

For more information, please use the links to the right.

View our corporate deck.

 

Share Price

Annual Report 2019

 

Corporate Presentation 

 

Cash at PureTech Parent Level

$321.5m PureTech Level Pro-forma Cash Reserves1

$120.6m PureTech Level Cash Reserves as of 31 December 20192

1. PureTech Level Pro-forma Cash Reserves is an alternative performance measure (APM) which includes the PureTech Level Cash Reserves of $120.6 million and the $200.9 million in proceeds from the 22 January 2020 sale of 2.1 million Karuna common shares. PureTech Pro-forma Cash Reserves is therefore considered to be more representative of the Corporate’s cash available for the year 2020 and beyond to advance product candidates within the full breadth of its operations.

2. PureTech Level Cash Reserves represent cash balances and short-term investments held at PureTech Health LLC, PureTech Management, Inc., PureTech Health PLC, PureTech Securities Corporation of $112.0 million for the year ended 2019 and the internal pipeline of $8.6 million for the year ended 2019, all of which are wholly-owned entities of PureTech, excluding cash balances and short-term investments of Controlled Founded Entities. The balance excludes the $200.9 million in proceeds from the 22 January 2020 sale of 2.1 million Karuna common shares.


Advisors

SOLICITORS
DLA Piper UK LLP
3 Noble Street
London EC2V 7EE
United Kingdom
TEL: +44 870 011 1111

INDEPENDENT AUDITOR
KPMG LLP
15 Canada Square
London  E14 5GL
United Kingdom
TEL: +44 207 311 1000

MEDIA / PR
FTI Consulting, Inc.
200 Aldersgate
Aldersgate Street
London EC1A 4HD
United Kingdom
TEL: +44 203 727 1000

Registrar

Our share register is managed and administered by Computershare Investor Services PLC.
Computershare Investor Services PLC should be able to help you with most questions you may have about your PureTech Health PLC shares. 

Computershare Investor Services PLC
The Pavilions, Bridgwater Road
Bristol BS99 6ZZ
United Kingdom

Telephone UK: 0800 408 0094
Telephone Overseas: +44 870 889 3159
Email: web.queries@computershare.co.uk

Analyst Coverage

PETER WELFORD
Jefferies International Limited
68 Upper Thames Street
London EC4V 3BJ
United Kingdom
TEL: +44 (0)20 7029 8000

AMY WALKER
Peel Hunt LLP
Moor House
120 London Wall
London EC2Y 5ET
United Kingdom
TEL: +44 (0)20 7418 8900

ALISTAIR CAMPBELL
Liberum
Ropemaker Place
25 Ropemaker Street
London EC2Y 9LY
United Kingdom
TEL: +44 (0)20 3100 2096

Placing